Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Posts Slight Rise in Q4 Revenues, Decrease in Net Losses

NEW YORK, Feb. 10 (GenomeWeb News) - Sequenom today reported an uptick in revenues for the fourth quarter ended Dec. 31, 2003, accompanied by narrowed losses and decreased R&D spending.

Sequenom's consolidated revenues for the quarter were $8.0 million, up slightly from $7.7 million in the year-ago period. The company's Genetic Systems business unit posted revenues of $7.7 million for the quarter, up from $7.2 million for the fourth quarter of 2002. Revenues for the company's pharmaceuticals business unit were down year-over-year, to $300,000 from $500,000 in the fourth quarter of 2002. Sequenom said these revenues resulted primarily from genetic services.

The company reported a 78 percent decrease in its net loss for the quarter, to $10.0 million, or $0.25 per share, from $45.8 million, or $1.16 per share, in the fourth quarter of 2002.

Sequenom's R&D expenses were $7.0 million for the fourth quarter, down from $8.0 million in the prior year.

On Dec. 31, 2003, Sequenom held cash, cash equivalents, short-term investments, and restricted cash totaling $67.5 million, compared to $102.6 million at the end of 2002.

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.